Baillie Gifford & Co’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-372	Closed	-$2.12K	–	348
2023 Q1	$2.12K	Hold	372	–	–	﹤0.01%	437
2022 Q4	$3.75K	Hold	372	–	–	﹤0.01%	458
2022 Q3	$8K	Hold	372	–	–	﹤0.01%	424
2022 Q2	$9K	Buy	+372	New	+$9K	﹤0.01%	422